Compare FORTY & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FORTY | ATEC |
|---|---|---|
| Founded | 1985 | 1990 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 1998 | 2006 |
| Metric | FORTY | ATEC |
|---|---|---|
| Price | $135.50 | $10.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | 471.0 | ★ 2.1M |
| Earning Date | 05-21-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.35% | N/A |
| EPS Growth | N/A | ★ 15.04 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $101,739,000.00 |
| Revenue This Year | N/A | $18.97 |
| Revenue Next Year | N/A | $16.70 |
| P/E Ratio | $36.65 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $85.30 | $10.11 |
| 52 Week High | $190.56 | $23.29 |
| Indicator | FORTY | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 54.50 | 36.57 |
| Support Level | $131.23 | N/A |
| Resistance Level | $136.43 | $16.05 |
| Average True Range (ATR) | 1.89 | 0.57 |
| MACD | 2.43 | 0.00 |
| Stochastic Oscillator | 99.21 | 6.07 |
Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources, Michpal, ZAP Group, and Others. The majority of the company's revenue comes from Israel.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.